Product ideation for pre-filled syringe market

Overview

Scientific informatics solutions are essential for translating complex regulatory, clinical, and market data into actionable product strategies. In this case study, Excelra applied its scientific informatics solutions to support product ideation and portfolio expansion for the US pre-filled syringe (PFS) market within critical care.

By leveraging integrated drug approval data and advanced analytics, Excelra enabled data-driven product ideation aligned with regulatory readiness and commercial viability. This engagement builds on Excelra’s expertise in scientific informatics services and drug lifecycle management platforms, ensuring insights across the full development continuum.

Our client

The client is a Europe-based small pharmaceutical company focused on critical care therapeutics. With an interest in expanding its generics portfolio in regulated markets, the organization sought scientific informatics solutions to identify differentiated and low-risk product opportunities in the US pre-filled syringe market.

Excelra partnered with the client as a provider of pharmaceutical scientific IT services, combining regulatory intelligence, clinical insights, and market analytics. This collaboration reflects Excelra’s broader role in supporting biopharma organizations through scalable and compliant informatics frameworks.

Client’s challenge

The client needed to identify commercially attractive PFS product ideas for critical care while navigating constraints related to patent expiry, regulatory approval, competition, and formulation complexity. Evaluating thousands of APIs and products across multiple geographies required harmonized, analysis-ready datasets.

This challenge demanded scientific informatics solutions capable of filtering noise, standardizing regulatory data, and enabling structured comparison across attributes such as dose precision, route of administration, and patent status. Excelra’s approach aligns with best practices outlined in its perspectives on using legacy and current data in drug development.

Client’s goals

The client’s objectives included:

• Identifying PFS product ideas with patent expiry on or before 2025
• Prioritizing opportunities suitable for the FDA-regulated US market
• Reducing risk from generic competition
• Accelerating entry into niche critical care segments

Achieving these goals required scientific informatics solutions that integrate regulatory, clinical, and market intelligence. Excelra’s capabilities in data curation and scientific data management ensured high-quality, decision-ready inputs.

Our approach

Excelra implemented a structured analytics workflow powered by its integrated drug approval and lifecycle management data. Products were filtered and ranked based on patents, formulation feasibility, geography, competition, clinical dose, and indication relevance.

Using scientific informatics solutions, Excelra performed detailed analysis, ranking, and prioritization to shortlist products addressing unmet critical care needs. The workflow leveraged Excelra’s expertise in data science and data visualization to translate complex comparisons into clear recommendations.

The outcome was a prioritized list of top five product ideas for the critical care PFS market, enabling a low-risk, high-value entry strategy.